Cecilia Jones serves as Executive at LogicBio Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Cecilia Jones has executed 17 insider transactions totaling $500.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 30, 2025 involved exercising options for 6,000 shares valued at $0.
Cecilia Jones currently holds 37,394 shares of LogicBio Therapeutics, Inc. (LOGC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cecilia Jones has been a net seller of LOGC stock. They have purchased $0 and sold $500.3K worth of shares.
Cecilia Jones's most recent insider trade was on Dec 30, 2025, when they sold 6,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $27.09 |
| Discretionary |
| Dec 30, 2025 | AGIO | $0 | Option Exercise | 6,000 | $N/A | Discretionary |
| Sep 26, 2025 | AGIO | $0 | Option Exercise | 7,472 | $N/A | Discretionary |
| Sep 26, 2025 | AGIO | $134.2K | Sale | 3,651 | $36.77 | Discretionary |
| Sep 26, 2024 | AGIO | $0 | Option Exercise | 7,473 | $N/A | Planned |
| Sep 26, 2024 | AGIO | $124.6K | Sale | 2,542 | $49.03 | Planned |
| Mar 5, 2024 | AGIO | $21.9K | Sale | 672 | $32.57 | Planned |
| Mar 1, 2024 | AGIO | $0 | Option Exercise | 2,000 | $N/A | Planned |
| Jan 24, 2024 | AGIO | $40.8K | Sale | 1,886 | $21.64 | Planned |
| Jan 20, 2024 | AGIO | $0 | Option Exercise | 5,380 | $N/A | Planned |
| Sep 28, 2023 | AGIO | $54.0K | Sale | 2,179 | $24.79 | Planned |
| Sep 26, 2023 | AGIO | $0 | Option Exercise | 7,472 | $N/A | Planned |
| Jun 30, 2023 | AGIO | $45.3K | Sale | 1,597 | $28.36 | Planned |
| Jun 28, 2023 | AGIO | $0 | Option Exercise | 5,380 | $N/A | Planned |
| Jan 12, 2022 | LOGC | $4.4K | Payment | 2,175 | $2.01 | Discretionary |
| Jan 11, 2022 | LOGC | $0 | Option Exercise | 5,939 | $N/A | Discretionary |